These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11000470)

  • 1. Enhancement of DNA vaccine potency by electroporation in vivo.
    Selby M; Goldbeck C; Pertile T; Walsh R; Ulmer J
    J Biotechnol; 2000 Sep; 83(1-2):147-52. PubMed ID: 11000470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancement of DNA vaccine potency in rhesus macaques by electroporation.
    Otten G; Schaefer M; Doe B; Liu H; Srivastava I; zur Megede J; O'Hagan D; Donnelly J; Widera G; Rabussay D; Lewis MG; Barnett S; Ulmer JB
    Vaccine; 2004 Jun; 22(19):2489-93. PubMed ID: 15193413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo.
    Widera G; Austin M; Rabussay D; Goldbeck C; Barnett SW; Chen M; Leung L; Otten GR; Thudium K; Selby MJ; Ulmer JB
    J Immunol; 2000 May; 164(9):4635-40. PubMed ID: 10779767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of human immunodeficiency virus type 1 subtype C gag, pol, and gagpol DNA and alphavirus replicon vaccines.
    Megede JZ; Otten GR; Doe B; Liu H; Srivastava R; Greer C; Legg H; Tang T; Polo JM; Donnelly JJ; Ulmer JB; Barnett SW
    Vaccine; 2006 Apr; 24(15):2755-63. PubMed ID: 16460840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-dependent inhibition of Gag cellular immunity by Env in SIV/HIV DNA vaccinated macaques.
    Valentin A; Li J; Rosati M; Kulkarni V; Patel V; Jalah R; Alicea C; Reed S; Sardesai N; Berkower I; Pavlakis GN; Felber BK
    Hum Vaccin Immunother; 2015; 11(8):2005-11. PubMed ID: 26125521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The site of administration influences both the type and the magnitude of the immune response induced by DNA vaccine electroporation.
    Vandermeulen G; Vanvarenberg K; De Beuckelaer A; De Koker S; Lambricht L; Uyttenhove C; Reschner A; Vanderplasschen A; Grooten J; Préat V
    Vaccine; 2015 Jun; 33(28):3179-85. PubMed ID: 25980430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
    Daemi A; Bolhassani A; Rafati S; Zahedifard F; Hosseinzadeh S; Doustdari F
    Immunol Lett; 2012 Dec; 148(2):117-25. PubMed ID: 23085605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice.
    Dupuis M; Denis-Mize K; Woo C; Goldbeck C; Selby MJ; Chen M; Otten GR; Ulmer JB; Donnelly JJ; Ott G; McDonald DM
    J Immunol; 2000 Sep; 165(5):2850-8. PubMed ID: 10946318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques.
    Luckay A; Sidhu MK; Kjeken R; Megati S; Chong SY; Roopchand V; Garcia-Hand D; Abdullah R; Braun R; Montefiori DC; Rosati M; Felber BK; Pavlakis GN; Mathiesen I; Israel ZR; Eldridge JH; Egan MA
    J Virol; 2007 May; 81(10):5257-69. PubMed ID: 17329330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation.
    Roos AK; Moreno S; Leder C; Pavlenko M; King A; Pisa P
    Mol Ther; 2006 Feb; 13(2):320-7. PubMed ID: 16185933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent immunogenicity of an HIV-1 gag-pol fusion DNA vaccine delivered by in vivo electroporation.
    Otten GR; Schaefer M; Doe B; Liu H; Megede JZ; Donnelly J; Rabussay D; Barnett S; Ulmer JB
    Vaccine; 2006 May; 24(21):4503-9. PubMed ID: 16181711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA prime/MVTT boost regimen with HIV-1 mosaic Gag enhances the potency of antigen-specific immune responses.
    Liu W; Wong YC; Chen SMY; Tang J; Wang H; Cheung AKL; Chen Z
    Vaccine; 2018 Jul; 36(31):4621-4632. PubMed ID: 29961605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skin targeted DNA vaccine delivery using electroporation in rabbits. I: efficacy.
    Medi BM; Hoselton S; Marepalli RB; Singh J
    Int J Pharm; 2005 Apr; 294(1-2):53-63. PubMed ID: 15814230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8
    Li SS; Kochar NK; Elizaga M; Hay CM; Wilson GJ; Cohen KW; De Rosa SC; Xu R; Ota-Setlik A; Morris D; Finak G; Allen M; Tieu HV; Frank I; Sobieszczyk ME; Hannaman D; Gottardo R; Gilbert PB; Tomaras GD; Corey L; Clarke DK; Egan MA; Eldridge JH; McElrath MJ; Frahm N;
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28931520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing efficacy of HIV gag DNA vaccine by local delivery of GM-CSF in murine and macaque models.
    Song R; Liu S; Adams RJ; Leong KW
    J Interferon Cytokine Res; 2006 Jun; 26(6):380-9. PubMed ID: 16734558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo electroporation improves immune responses to DNA vaccination in sheep.
    Scheerlinck JP; Karlis J; Tjelle TE; Presidente PJ; Mathiesen I; Newton SE
    Vaccine; 2004 Apr; 22(13-14):1820-5. PubMed ID: 15068866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal and systemic anti-GAG immunity induced by neonatal immunization with HIV LAMP/gag DNA vaccine in mice.
    Goldoni AL; Maciel M; Rigato PO; Piubelli O; de Brito CA; Melo A; Marques ET; August JT; Duarte AJ; Sato MN
    Immunobiology; 2011 Apr; 216(4):505-12. PubMed ID: 20870310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo electroporation in DNA-VLP prime-boost preferentially enhances HIV-1 envelope-specific IgG2a, neutralizing antibody and CD8 T cell responses.
    Huang X; Zhu Q; Huang X; Yang L; Song Y; Zhu P; Zhou P
    Vaccine; 2017 Apr; 35(16):2042-2051. PubMed ID: 28318765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene.
    zur Megede J; Chen MC; Doe B; Schaefer M; Greer CE; Selby M; Otten GR; Barnett SW
    J Virol; 2000 Mar; 74(6):2628-35. PubMed ID: 10684277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques.
    Hirao LA; Wu L; Khan AS; Satishchandran A; Draghia-Akli R; Weiner DB
    Vaccine; 2008 Jan; 26(3):440-8. PubMed ID: 18082294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.